Objective: To assess the association of dietary flavonol intake with the subsequent risk of coronary heart disease (CHD) mortality. Design: Meta-analysis of prospective cohort studies published before September 2001. Studies were identified by MEDLINE and EMBASE searches and by scanning relevant reference lists. The following information was extracted from published reports: size of cohort, mean age, mean duration of follow-up, number of fatal CHD events, mean flavonol intake, main sources of flavonol intake, degree of adjustment for potential confounders, and the relation of CHD mortality to dietary flavonol intake measured at baseline. Results: Seven prospective cohorts of men and women were identified including a total of 2087 fatal CHD events. Comparison of individuals in the top third with those in the bottom third of dietary flavonol intake yielded a combined risk ratio of 0.80 (95% CI 0.69-0.93) after adjustment for known CHD risk factors and other dietary components. Conclusion: This overview of prospective cohort studies indicates that high dietary intake of flavonols from a small number of fruits and vegetables, tea and red wine may be associated with a reduced risk from CHD mortality in free-living populations.
Introduction
There is a large body of evidence to suggest that high dietary intakes of fruit and vegetables are associated with reduced risk of cardiovascular disease, stroke and cancer (Ness & Powles, 1997) . Fruits and vegetables are rich sources of antioxidants, which are thought to inhibit oxidation of lowdensity lipoprotein (LDL) cholesterol, a process that is considered to be a prerequisite for atherosclerosis (Witztum & Steinberg, 1991) . Recently, attention has been focused on the possible cardio-protective and anticarcinogenic properties of flavonoids, a group of polyphenolic compounds that occur naturally in fruits and vegetables, tea and red wine (Hollman & Katan, 1999) .
In experimental studies, flavonoids have been shown to have both antioxidant (Kandaswami & Middleton, 1994) and antithrombotic properties (Gryglewski et al, 1987) and to be effective chelators of transitional metals that catalyse cellular oxidation reactions (Aherne & O'Brien, 2000) . However, whether these properties translate into a reduction in risk of coronary heart disease (CHD) and cancer in human populations is still unknown.
Onions, apples, broccoli, tea and red wine are rich in flavonols (a subclass of flavonoids) and are the main dietary sources of these compounds in Western populations (Hollman & Katan, 1999) . Accordingly, flavonol intakes have been reported to vary widely across countries (Hertog et al, 1995) with some of the lowest intakes being reported for Northern European populations (Knekt et al, 1996) , while populations from the US (Yochum et al, 1999) and other European countries have among the highest reported intakes.
Epidemiological studies that have examined the association between flavonol intakes and CHD mortality have reported conflicting findings, with studies reporting either a moderate (Yochum et al, 1999) or no protective effect with high dietary intakes of flavonols after adjustment for cardiovascular risk factors and potential dietary confounders. However, few studies were large enough to be able to reliably detect an association between flavonol intakes and fatal CHD events. We have, therefore, conducted a systematic review (meta-analysis) of all studies that have reported on the association between flavonol intakes and CHD mortality.
Methods
All prospective cohort studies from 1966 to August 2001 that reported on the association between dietary intake of flavonols and CHD mortality were identified through MED-LINE and EMBASE using the key terms 'flavonols', 'flavonoids' and 'CHD'. Additional studies were identified from references in these papers and from review articles. If more than one article had been published for a particular study, then only the article with the largest number of CHD events was included in the analysis. Study estimates of dietary flavonol intake from food frequency questionnaires were obtained by multiplying the frequency of consumption by the flavonol content of the foodstuff.
The log risk ratio for CHD mortality among individuals in the top third vs those in the bottom third of flavonol intake was estimated from the original published report, assuming a log-linear relation with CHD mortality over the mid-range of values for flavonol intakes. Where the adjusted log risk ratio was not directly available from the study, it was estimated as 2.18/2.54 times the log risk ratio for the comparison of the top and bottom quartiles or 2.18/2.80 times the log risk ratio for the comparison of the top and bottom quintiles (Danesh et al, 1998) . The standard error, s, of the log risk ratio b, was estimated from the approximation s 2 ¼ 2.18 (1/n 1 + 1/n 2 ), where n 1 is the number of individuals who had died from CHD and n 2 is the number who were still alive. Summary estimates of the risk ratios from all studies were obtained by combining the separate estimates of inverse-varianceweighted log risk ratios from each study. In total, 95% CI (b71.96s) were obtained by normal approximation for the individual studies and the overall summary estimate. Heterogeneity between studies was assessed using the w 2 statistic. The level of adjustment within each study was denoted as * if the study adjusted for age, sex, BMI and blood pressure,** if additional adjustment was made for dietary components including cholesterol and saturated fat and *** if there was additional adjustment for some measure of social class.
Results
A total of eight published studies have reported on the association between flavonol intakes with CHD mortality. However, one of these studies had an ecological study design and was therefore excluded from the analysis. Our analysis was therefore based on data from seven prospective cohort studies in men and women aged between 30 and 84 y, which included individual data on approximately 105 000 people (Table 1) . Six of these studies reported an inverse association between estimated flavonol dietary intake with CHD mortality. The mean duration of follow-up ranged from 6 to 26 y and the combined number of fatal CHD events was 2087. The mean daily intake of flavonols ranged from between 2 and 434 mg and in those populations with the highest reported flavonol intakes, tea was the primary source, whereas in the cohorts with the lowest reported levels, fruits and vegetables were the principle sources of flavonols.
In four of the seven studies, dietary information was assessed at baseline using a food-frequency questionnaire. These questionnaires had been internally validated against 7 day-weighed food diaries in subsamples of the cohorts. In the remaining three studies, information on diet was obtained from an interview with a trained dietitian. Each study calculated the flavonol content of individual foods on the basis of composition analyses by Hertog et al (1992 Hertog et al ( , 1993 . Food composition tables were used to obtain nutrient values for all other food stuffs.
The overall summary estimate for the adjusted relative risk was a 20% reduction (RR 0.80, 95% CI 0.69 -0.93) in CHD mortality between those individuals in the top third vs those in the bottom third of flavonol intakes (Figure 1) , with evidence of significant heterogeneity between the studies (w 2 ¼ 38.60, df ¼ 6, Po0.001). Sensitivity analysis showed that after excluding the Welsh cohort (Hertog et al, 1997a, b) from the analysis, which reported a positive association of flavonol intake with CHD mortality, there was no longer any evidence of significant heterogeneity between the studies (w 2 ¼ 11.31, df ¼ 5, 0.05oPo0.1). Excluding this study from the pooled estimate had little impact on the overall effect size (RR ¼ 0.77, 95% CI 0.66-0.90). Additional sensitivity analyses indicated that the point estimate and CI for the risk reduction were not significantly altered with the exclusion of any individual study although the reduction of risk to 0.74 (95% CI 0.63-0.87) with the exclusion of the study by Hirvonen et al (2001) suggests that this cohort, which had the largest number of events, was the most influential.
Discussion
This current overview of the literature suggests that high dietary intakes of flavonols are inversely associated with CHD risk. Individuals in the top tertile of dietary flavonol intakes have a 20% lower risk from CHD mortality compared with individuals in the lower tertile of intakes, an effect which is independent of other dietary components and known CHD risk factors. This meta-analysis however has several limitations. Firstly, as is common in all epidemiological studies that attempt to examine the relation between diet and disease, the results of this over-view are limited by misclassification of dietary exposures. It is likely that the food questionnaires used in each of these studies were not originally designed to measure flavonol intake, as the potential importance of flavonols to the diet was only recently suggested in the early 1990s. Moreover, information on risk factors for CHD was based on self-report in each of the cohorts, potentially confounding any association between flavonol intakes with CHD mortality. For example, flavonol intakes have been reported to be associated with known CHD risk factors including social Black squares indicate the risk ratio in each study, with the square size proportional to the number of CHD fatal events and the horizontal lines representing 95% CI. The combined risk ratio and its 95% CI is denoted by the black diamond. * indicates level of adjustment; **, adjustment for age sex, smoking, BMI, blood pressure, dietary cholesterol and fat intake; ***, for these plus some measure of social class.
class , physical activity and smoking rates (Yochum et al, 1999) . Even though all studies adjusted for smoking and five studies attempted to adjust for some measure of social class, it is difficult to entirely eliminate confounding by these factors and therefore some degree of residual confounding is likely to remain. Furthermore, although all studies adjusted for the effects of other dietary components such as fruit and vegetable consumption, energy, cholesterol and fat intake, the presence of measurement error would make it likely that these factors were incompletely controlled for in the separate analyses. Therefore, residual confounding and incomplete adjustment for other dietary components may explain some of the observed 20% reduction in CHD risk reported in this overview. In addition, there are a number of difficulties in assessing flavonol intakes from food-frequency questionnaires. Firstly, the accuracy of self-reported measurements is uncertain and since flavonols are found concentrated in only a few foods, errors in the reporting of intakes of these foods may result in large errors in estimated flavonol intakes. In addition, all the studies based their calculations of flavonol intake based on the same composition analyses of Hertog et al (1992 Hertog et al ( , 1993 , which were based on Dutch-food composition data that may have introduced inaccuracies in the estimation of flavonol intakes in the cohorts from the US and from other European countries. Furthermore, as the flavonol content of many foods is unknown and the bioavailability of flavonols has been shown to vary widely between food (Hollman & Katan, 1999) , this is likely to underestimate any association between flavonol intake and CHD risk.
Moreover, the possibility that publication bias may have contributed to overestimating the pooled estimate cannot be excluded. However, the observation that there was no clear tendency for the smaller cohorts to report much larger effect estimates compared with the larger studies suggests that the influence of selective publication on the pooled estimate is likely to be minimal.
The finding that flavonol intakes may influence CHD risk is in agreement with the findings from a number of large observational studies that have reported significant effects of other dietary components on CHD risk. For example, dietary intakes of vitamin C (Khaw et al, 2001) , fruit and vegetables (Liu et al, 2000) and fibre (Pietinen et al,1996) have been reported to be positively and independently associated with lower CHD risk. However, results from randomised trials (Pietinen et al,1996; GISSI, 1999 , HPS, 2002 of the effects of supplementation with vitamins C and E on CHD mortality have not supported the hypothesis that increased consumption of antioxidants is associated with lower CHD risk. But, the relation between diet and CHD is complex and unlikely to be solely determined by any individual dietary component. Flavonols occur most abundantly in a limited number of foodstuffs including tea, apples, onions, broccoli, tomatoes and red wine. Several of these foods are key ingredients in the Mediterranean diet, which besides being rich in fruit and vegetables is also low in saturated fat and cholesterol.
Numerous observational studies have reported that the Mediterranean diet is associated with lower CHD risk compared with Northern European diets, which are characterised by higher saturated fat intake and lower consumption of fruit and vegetables (Trichopoulou & Vasilopoulou, 2000) .
Only one study identified in this review showed a positive association between flavonol intake and CHD risk. In this cohort of Welsh men , flavonol intake was mostly in the form of tea rather than from fruits and vegetables. Tea consumption was negatively associated with social class in this population, an observation that led the authors to suggest that the positive correlation between flavonol consumption and incidence of CHD was because of confounding by social class. Furthermore, there is some evidence to suggest that the addition of milk to tea reduces the gastrointestinal absorption of flavonols because of the binding of the flavonols to milk proteins, thereby potentially inhibiting the antioxidant effect of tea (Serafini et al, 1996) . Moreover, the bioavailability of flavonols from tea has been shown to be only about 50% of that from other sources such as onions (Hollman & Katan, 1999) suggesting that flavonol intake from tea may not be as beneficial as that derived from fruits, vegetables and red wine. In support of this, subgroup analyses of specific sources of flavonols with CHD mortality indicated that tea consumption was unrelated to CHD risk after adjustment for dietary factors Yochum et al, 1999) , whereas high intakes of flavonols from vegetable sources, such as broccoli and onions, were significantly and inversely associated with CHD mortality Yochum et al, 1999; Hirvonen et al, 2001 ).
This overview is unable to specify the level of flavonol intake above which a beneficial effect in terms of a reduction in CHD mortality is conferred, as the mean flavonol intake within individual studies varied widely. There was no evidence from the individual studies that there is a continuous relation between flavonol consumption and reduced CHD mortality. Most studies reported the adjusted relative risk for CHD mortality by tertile, quartile or quintile of flavonol intake. Although six of the seven cohorts reported reduced risk of CHD mortality when those individuals with the highest flavonol intakes were compared with those with the lowest intakes, when test for trends were performed across the distribution of intakes, only one study reported a significant association . However, this may be because of an insufficient number of events in each of the subgroups to be able to detect a significant trend.
In summary, the finding from this review, that high intakes of flavonols may be associated with a moderate reduction in CHD risk in free-living populations, suggests that flavonol intake may be a modifiable dietary risk factor in CHD prevention. Therefore, strategies that increase flavonol consumption in the general population by specifically targeting those foodstuffs that are especially rich in flavonols, such as tomatoes, broccoli, onions, apples and red wine, may have a beneficial impact on lowering CHD incidence.
